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Abstract
The assessment of physical activity in healthy populations and in those with chronic diseases is challenging. The
aim of this systematic review was to identify whether available activity monitors (AM) have been appropriately
validated for use in assessing physical activity in these groups. Following a systematic literature search we found
134 papers meeting the inclusion criteria; 40 conducted in a field setting (validation against doubly labelled water),
86 in a laboratory setting (validation against a metabolic cart, metabolic chamber) and 8 in a field and laboratory
setting. Correlation coefficients between AM outcomes and energy expenditure (EE) by the criterion method
(doubly labelled water and metabolic cart/chamber) and percentage mean differences between EE estimation from
the monitor and EE measurement by the criterion method were extracted. Random-effects meta-analyses were
performed to pool the results across studies where possible. Types of devices were compared using meta-
regression analyses. Most validation studies had been performed in healthy adults (n = 118), with few carried out in
patients with chronic diseases (n = 16). For total EE, correlation coefficients were statistically significantly lower in
uniaxial compared to multisensor devices. For active EE, correlations were slightly but not significantly lower in
uniaxial compared to triaxial and multisensor devices. Uniaxial devices tended to underestimate TEE (−12.07 (95%CI;
-18.28 to −5.85) %) compared to triaxial (−6.85 (95%CI; -18.20 to 4.49) %, p = 0.37) and were statistically significantly
less accurate than multisensor devices (−3.64 (95%CI; -8.97 to 1.70) %, p<0.001). TEE was underestimated during
slow walking speeds in 69% of the lab validation studies compared to 37%, 30% and 37% of the studies during
intermediate, fast walking speed and running, respectively. The high level of heterogeneity in the validation studies
is only partly explained by the type of activity monitor and the activity monitor outcome. Triaxial and multisensor
devices tend to be more valid monitors. Since activity monitors are less accurate at slow walking speeds and
information about validated activity monitors in chronic disease populations is lacking, proper validation studies in
these populations are needed prior to their inclusion in clinical trials.
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Systematic review
Introduction
There is evidence that regular physical activity is asso-
ciated with a reduced risk of mortality and contributes
to the primary and secondary prevention of several
chronic diseases [1]. For example, a reduced risk of cor-
onary heart disease, cardiovascular disease, stroke and
colon cancer has been reported in more active indivi-
duals [2]. In patients with chronic obstructive pulmonary
disease (COPD), regular physical activity leads to a lower
risk of both COPD related hospital admissions and mor-
tality [3]. Physical activity limitation is a major problem
in patients with chronic diseases and needs to be accur-
ately measured if therapies aimed at improving this are
to be properly evaluated. A range of devices are available
for this purpose but most have been validated in young,
healthy subjects and their applicability to older or unwell
populations, where movements tend to be slower, is not
well established.
Physical activity is defined as any bodily movement, pro-
duced by skeletal muscles, requiring energy expenditure
[4]. Daily physical activity can be considered as “the total-
ity of voluntary movement produced by skeletal muscles
during everyday functioning” [5]. Estimates of daily phys-
ical activity can be obtained by different approaches; ques-
tionnaires, energy expenditure measurements and activity
monitors. Questionnaires rely on the subject’s recollection
of activities and allow categorization of patients by phys-
ical activity (very active, active, sedentary and inactive) [6],
but may lack the precision needed to detect changes in
physical activity on a day to day basis.
Daily physical activity can be expressed as an overall
measure of active energy expenditure, using indirect cal-
orimetry techniques such as doubly labelled water or
metabolic carts. Although doubly labelled water is
regarded as a criterion method, this technique does not
quantify the duration, frequency and intensity of physical
activity performed. Metabolic cart systems which meas-
ure expired O2 and CO2 however cannot be used over
extended periods of time.
Physical activity can also be monitored directly using
physical activity monitors. In general, three classes of
Figure 1 Flow chart describing the identification and inclusion of relevant studies.
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Table 1 Overview uniaxial activity monitors used in validation papers
Name Manufacturer Field(F)/Lab(L) +
reference
Size
(and weight)
Placement Cost Epoch length Data storage Outcomes (measured) Outcomes (calculated)
Actigraph Model
7164 (formerly
CSA, MTI)
Actigraph LLC
Pensacola, FL
F [14-24] +
L [7,25-47]
5.1 x 4.1 x
1.5 cm (45.5 g)
hip, ankle
or wrist
NA 5 s to 1 min. 22 days
(1 min epochs)
AC, steps EE, activity intensity level
Actigraph Model
GT1M
Actigraph LLC
Pensacola, FL
F [48-50] +
L [29,49,51-57]
3.8 x 3.7x
1.8 cm (27 g)
hip, ankle
or wrist
€239 (unit),
€249 (software)
1 s to several
minutes
378 days
(1 min epochs)
AC, steps EE, activity intensity level
Caltrac Muscle Dynamics
Fitness Network,
Torrance, USA
F [58-62] +
L [7,34,35,63-65]
7 x 7 x 2 cm waist €71 (unit) NA no data storage AC EE
Kenz Lifecorder
EX
Suzuken Co Ltd.,
Nagoya, Japan
F [66,67] +
L [51,68-70]
7.25 x 4.15 x
2.75 cm (40 g)
waist €49 (unit) +
€250 (software)
5 s to 10 min 200 days Steps, activity level EE, activity intensity level
Calorie Counter
Select II
Suzuken Co Ltd.,
Nagoya, Japan
L [7,71] 5 x 3 x 1 cm waist NA 1 day 7 days steps EE
ActivPAL PAL Technologies
Ltd, Glasgow, UK
L [57,72-74] 5 x 3,5 x
0,7 cm (15 g)
midline on the
anterior aspect
of the thigh
NA 1 s to 1 min 10 days Steps (cadence),
different body positions,
activity score
PALlite PAL Technologies
Ltd, Glasgow, UK
L [74] 5 x 3.5 x
0.7 cm (20 g)
ankle €239 1 s to 1 min 10 days Steps
PAM model
AM101B.V.
Doorwerth,
Netherlands
L [37] 5.8 x 4.2 x
1.3 cm (28 g)
waist NA 1 s to 1 min. 3 months PAM scores
Actiwatch Mini Mitter Co,
Sunriver, OR, USA
L [75] 4.4 x 2.3 x
1 cm (16.1 g)
wrist €713 (unit),
€213 (reader)
15 s to 1 min 30 days
(1 min epochs)
AC
Biotrainer IM Systems,
Baltimore, MD, USA
L [41,64,76] 7x 7 x
2 cm (51.1 g)
hip NA NA 9 days AC EE
Nike and
iPod sensor
Apple Inc,
Cupertino, CA, USA
L [77] 2,4 x 3,5 x
0,8 cm (9 g)
shoe €19 (sensor) NA 16 GB Ground contact time Distance, speed, EE
Polar Activity
Watch 200
Polar Electro Oy,
Kempele, Finland
L [78] NA wrist €152
(watch + software)
1 min Up to 9 files Steps, HR EE, activity intensity level
Field study (F), lab study (L) or field + lab study (F + L). PAM; physical activity monitor, AC; activity counts, HR; heart rate, ECG; electrocardiogram, EE; energy expenditure, NA; not available, HR; heart rate.
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activity monitors are being used increasingly in chronic
disease populations (e.g. COPD): pedometers, acceler-
ometers and integrated multisensor systems. Pedometers
are devices which estimate the number of steps taken
through mechanical or digital measurements in only the
vertical plane. This is a limited measure of physical ac-
tivity [7,8]. Accelerometers detect acceleration in one,
two or three directions (uni-, bi- or triaxial acceler-
ometers). These devices allow determination of the
quantity and intensity of movements [9]. Integrated mul-
tisensor systems combine accelerometry with other sen-
sors that capture body responses to exercise (e.g. heart
rate or skin temperature) in an attempt to optimise
physical activity assessments.
With the advancement of technology, the number of
activity monitors available to measure physical activity is
growing. However, despite these advances, it remains a
challenge to assess physical activity in slowly moving
patients (such as those with COPD, chronic heart failure
and diabetes type II) [10-12]. In these patients small
changes in physical activity are likely to be important
effects of interventions aimed at enhancing physical ac-
tivity. Therefore, in order for investigators to interpret
the effect of interventions on physical activity, activity
monitors that have been properly validated in these pa-
tient groups are needed.
In order to make evidence based statements on the
validity of activity monitors, a systematic review was
conducted to identify available activity monitors that
have been validated in both healthy adults and chronic
disease populations.
Methods
Inclusion criteria
Studies meeting the following criteria were included: (1)
Population: healthy adults and adults with a diagnosis of
chronic disease in whom inactivity is a likely contributor
to morbidity or a target for treatment, but whose loco-
motor function is relatively preserved (COPD, heart
failure, diabetes type II, frail elderly, primary pulmonary
hypertension, chronic low back pain, fibromyalgia syn-
drome, obesity). (2) Measurement: any commercially
available activity monitor for outdoor activity monitoring
from uniaxial to triaxial accelerometers and multisensor
devices to tools incorporating spatial information (e.g.
GPS) or other information on motion. (3) Study design:
studies that evaluated the validity of an activity monitor,
i.e. testing an activity monitor against a criterion
method, such as indirect calorimetry. Two types of val-
idation studies were included; field validation studies
(validation of an activity monitor against doubly labelled
water) and laboratory validation studies (validation of an
activity monitor using a metabolic cart or metabolic
chamber and/or manual step-counting or video observa-
tion). (4) Clinical trials using activity monitoring as an
outcome and which might contain a reference to a valid-
ation paper were included for hand-searching. (5) A
search window between 1st of January 2000 until 1st of
March 2012 was selected in order to capture sensors in
contemporary use. This approach still allowed for the
identification of older validation studies (published be-
fore 2000) of devices in current use in clinical trials.
Main exclusion criteria were 1) studies in children (sub-
jects younger than 18 years), 2) studies in subjects with
abnormal biomechanical movement patterns (e.g. cere-
bral palsy, lower limb amputation), 3) studies only inves-
tigating the number of steps using pedometers because
of the inaccuracy in measurement of total energy ex-
penditure [7] and lack of ability to measure physical ac-
tivity patterns [8].
No language restrictions were used; any non-English
studies retrieved through the literature search were trans-
lated to determine their appropriateness for inclusion.
Search strategy and systematic review
Eligible studies were identified by searching the follow-
ing databases: MEDLINE, EMBASE and CINAHL. A li-
brarian was consulted prior to initiating the search in
Table 2 Overview biaxial activity monitors used in validation papers
Name Manufacturer Field(F)/Lab(L) +
reference
Size (l x w x h)
and (weight)
Placement Cost Epoch
length
Data
storage
Outcomes
(measured)
Outcomes
(calculated)
Biotrainer
Pro
IM Systems,
Baltimore,
MD, USA
L [32] 7.6 x 5 x 2.2
cm (51.1 g)
hip €142 (unit),
€142 (software),
€70 (cable)
15 s to
5 min
22 days
(1 min epochs)
AC, steps,
activity
intensity level
EE
Actitrac IM Systems,
Baltimore,
MD, USA
L [76] 5.6 x 3.8 x 1.3
cm (34 g)
wrist €570 (unit),
€285 (software),
€70 (cable)
2 s to
2 min
44 days
(1 min epochs)
AC
AMP-331 Activity Monitoring
Pod, Dynastream
Innovations Inc.,
Cochrane,
AB, Canada
L [26,38] 7,13 x 2,4 x
3,75 cm (50 g)
right ankle
(directly
over the
Achilles
tendon)
NA 1 min
epochs
28 hours
(1 min epochs),
3.5 days
(3 min epochs)
steps, cadence,
walking speed,
stride length,
distance
EE
Field study (F), lab study (L) or field + lab study (F + L). AC; activity counts, EE; energy expenditure, NA; not available.
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Table 3 Overview triaxial activity monitors used in validation papers
Name Manufacturer Field(F)/Lab(L)
+ reference
Size (l x w x h)
and (weight)
Placement Cost Epoch
length
Data
storage
Outcomes
(measured)
Outcomes
(calculated)
Actigraph GT3x Actigraph LLC
Pensacola, FL
L [79] 4.6 x 3.3 x
1.5 cm (19 g)
Hp, ankle
or wrist
€936 (device
+ software)
1 s to
1 min
19 days VMU, steps EE, activity
intensity
level
RT3- Research
Tracker
Stayhealthy Inc.
Monrovia, CA
F [80,81] + L
[32,38,54,55,
80,82,83]
7.1 x 5.6x
2.8 cm (65.2 g)
hip or waist €142 per
unit, €214
for docking
station
1 s to
1 min
21 days AC, VMU EE
TriTrac R3D Hemokinetics Inc,
Madison, WI
F [14,16,80] +
L [31-33,41,63,
75,80,82,84-86]
10.8 x 6.8 x
3.3 cm (170.4 g)
waist $500 1 min 14 days AC, VMU EE
Tracmor Philips Research,
Eindhoven, The
Netherlands
F [87-94] +
L [95-97]
7.2 x 2.6x
0.8 cm (22 g)
waist €142 per
unit, €214
for docking
station
NA 21 days AC EE
TracmorD (Philips
DirectLife)
Philips New
Wellness Solutions
F [98] 3,2 x 3,2 x
0,5 cm (12,5 g)
Lower back €113 NA 22 weeks AC EE
Dynaport activity
monitor
McRoberts BV,
The Hague, The
Netherlands
F [99] 12.5 x 9.5 x
3 cm (375 g)
waist + one
leg sensor
(thigh)
€4900
(+software)
1 s to
1 min
2 days
(continuously)
More days if
SD memory
card is used
movement
intensity,
different
body
positions
Dynaport
minimod
McRoberts BV,
The Hague, The
Netherlands
L [100,101] 8.5 x 5 x
1 cm (70 g)
waist €1500 (unit) 1 s to
1 min
7 days movement
intensity,
different
body
positions,
steps
EE
Biotel 3dNx Biotel Ltd,
Bristol, UK
F [102] +
L [29,103]
12.5 x 5.8 x
0.8 cm
hip or waist €800 5 s to 60s 700 days VMU EE
Actimarker,
EW4800P
Panasonic Electric
Works Co Ltd,
Osaka, Japan
F [67] 6 x 3.5 x
1.3 cm (24 g)
waist €86 (device) 1 min 180 days VMU EE
ActivTracer GMS, Tokyo,
Japan
L [104] 4.8 x 6.7 x
1.6 cm (57 g)
waist VMU EE, activity
intensity
level
Actical Mini Mitter Co,
Sunriver, OR, USA
F [105] +
L [26,38,44,
54,106-112]
2.8 x 2.7 x
1.0 cm (17.5 g)
hip, ankle
or wrist
€678 (incl.
software)/
€321 (unit)
15 s to
1 min.
45 days
(1 min
epochs)
AC, steps EE, activity
intensity
level
e-AR (earworn
activity
recognition
sensor)
Sensixa Ltd,
London, UK
L [113] 5,6 x 3,5 x
1,0 cm (7.4 g)
ear NA 1 min NA AC EE
PASE (Physical
Activity Sensing
Earpiece)
MMA7260Q,
Freescale
Semiconductor,
Austin, Texas
L [114] 0,6 x 0,6 x
0,14 cm (40 g,
including data
logging system)
ear NA 15 s to
1 min.
NA Acceleration
units
EE, activity
intensity
level
GENEA Unilever Discovery,
Sharnbrook
Bedfordshire, UK
F [115] +
L [55]
3,6 x 3,0 x
1,2 cm (16 g)
Wrist, waist,
ankle
NA NA 8 days VMU EE
Activity Style
Pro HJA-350IT
Omron Healthcare,
Kyoto, Japan
L [116] 7.4 x 4.6 x
3.4 cm (60 g)
waist NA NA NA VMU Activity
intensity level
CAM (Continuous
Activity Monitor)
Maastricht
Instruments B.V.
L [117] 6.3 x 4.5 x 1.8 (102 g) leg NA NA NA VMU Activity
intensity level,
Different body
positions
Field study (F), lab study (L) or field + lab study (F + L). AC; activity counts, VMU; vector magnitude units, EE; energy expenditure, NA; not available.
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Table 4 Overview multisensor activity monitors used in validation papers
Name Manufacturer Field(F)/Lab(L)
+ reference
Size (l x w x h)
and (weight)
Placement Cost Epoch
length
Data
storage
Outcomes
(measured)
Outcomes
(calculated)
PAMS (Physical Activity
Monitoring System)
ICSensors 3031–010, Druck,
The Netherlands
L [118] 5,0 x 3,0 x 0,8 cm
(Tracmor, 16 g) + 4 tilt
sensors (total
weight = 1,3 kg)
lower back (Tracmor) +
lateral aspect of the
trunk and to the lateral
aspect of the mid-thigh
(sensors)
NA NA NA voltage units body position
(lying, sitting, standing)
Actireg Premed AS, Oslo, Norway F [119,120] +
L [46]
8.5 x 4.5 x 1.5 cm
(60 g)
waist (storage unit) +
chest and right
thigh (sensors)
€440
(device) +
€380
(software)
1 s to
1 min
30 days body position
and movement
Activity intensity
level, EE
Vitaport (+ 4 uniaxial
accelerometers (ADXL202))
University of Cologne, Cologne,
Germany (Vitaport)/Analog devices,
Breda, The Netherlands
(Uniaxial accelerometers)
L [121] 1.5 x 1.5 x 1 cm
(uniaxial accelerometer,
8 g)/6 x 11 x 3 cm
(Vitaport, data
recorder, 500 g)
4 sensors: 2 on skin
of the ventral side of
each thigh, 2 on the
skin of the sternum,)
€ 15.000 1 s to
1 min
3 days acceleration
units
motility legs,
motility trunk,
motility body
Sensewear Pro Armband
(formerly Healthwear Armband)
Bodymedia, Pittsburgh, PA, USA F [50,122-126] +
L [32,46,100,
125-138]
8.8 x 5.6 x 2.1 cm
(82 g)
Upper right arm
at triceps
(midhumerus point)
€800
(device) +
€1597
(software)
1 min 14 days Steps, activity
intensity level
EE
SenseWear Mini Armband Bodymedia, Pittsburgh, PA, USA F [124] NA Upper left arm
at triceps
(midhumerus point)
€722
(device) +
€1597
(software)
1 s to
1 min
28 days Steps, activity
intensity level
EE
Actiheart Mini Mitter Sunriver, OR, USA L [29,108,139] 0.5 x 1.1 x 2.2 cm (clip) +
10 cm (wire) (10 g)
3th intercostals
space (clip) + 2 ECG
electrodes (chest)
€1330 15 s to
1 min
11 days
(1 min
epochs)
Acceleration HR,
HR variability,
ECG amplitude
EE
Ikcal Teltronic AG, Biberist, Switzerland L [46] NA Chest (elastic belt
around the sternum)
NA NA NA Acceleration, HR EE
Multi-sensor board Department of Epidemiology,
University of Washington, USA
L [111] 25 g Hip NA 1 s to
1 min
NA Steps, activity
intensity level,
different body
positions
EE
IDEEA (Intelligent Device for
Energy Expenditure and Activity)
MiniSun, LLC, Fresno, CA, USA F [140] +
L [141]
7 x 5.4 x 1.7 cm (59 g)
(recorder) + 1.8 x 1.5 x
0.3 cm (2 g) (sensor)
Waist (processing unit)
+ sole of both feet,
both thighs and
chest (sensors)
NA 1 s to
1 min
7 days Activity code,
speed, distance,
power output
EE
Field study (F), lab study (L) or field + lab study (F + L). AC; activity counts, EE; energy expenditure, NA; not available.
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order to identify appropriate search terms to describe
the population (from healthy adults to patients with
chronic disease), physical activity and activity monitor-
ing. A combination of MeSH terms (MEDLINE), Emtree
terms (Embase) and Cinahl headings (Cinahl) with free
text words (all databases) were used (see Additional file
1 for detailed information). Refworks (www.refworks.
com) was used to store and share all papers and to col-
lect all the information of title and abstract screening,
full text assessment and the hand-searching process.
Each review team consisted of 3 reviewers who inde-
pendently screened the titles and abstracts of the
retrieved articles. Each abstract was labelled as ‘A)
excluded papers‘, ‘B) order for full text assessment‘or ‘C)
hand-search for references only’, i.e. clinical trials which
may have a reference to an older validation study. After
independently reviewing the articles for inclusion, the
reviewers compared their labels to ensure consensus.
Once agreement had been reached, a full text copy of
each article that met the inclusion criteria was obtained
(Label B). Thereafter, the same review teams looked at
the full texts of the potential validation papers in detail
and decided in consensus, whether the articles were in-
deed suitable validation papers for data extraction. Sub-
sequently, hand-searching of the clinical trials using an
activity monitor outcome which might contain a refer-
ence to a validation paper (Label C), was performed by
three independent reviewers. After independently
reviewing these full texts, validation papers were identi-
fied which met the inclusion criteria for full text assess-
ment. Again, the reviewers compared their decisions to
ensure consensus. Data of all included validation papers
were extracted into predefined prepared Excel tables.
Data extraction
For the field studies, correlation coefficients between
total and active energy expenditure from activity
monitor (TEEAM and AEEAM respectively) and total
Figure 2 Study-specific correlation coefficients (r) and Fisher z-scores (diamond) between total energy expenditure estimate from the
activity monitor (TEEAM) and total energy expenditure measure from doubly labelled water (TEEDLW). Each dot represents the z-score of
the respective study together with a 95% confidence interval (CI) and the size of the box represents the weight of the study in the meta-analysis.
Weights are from random effects analysis. CV; coefficient of variation for TEEDLW.
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and active energy expenditure measured with doubly la-
belled water (TEEDLW and AEEDLW respectively) were
extracted. The percentage mean differences (ΔTEE and
ΔAEE) with 95% confidence intervals were obtained
from the reports to assess agreement between energy
expenditure estimates from the activity monitor
(TEEAM and AEEAM) versus energy expenditure mea-
sures from doubly labelled water (TEEDLW and
AEEDLW). For the laboratory studies, correlation coeffi-
cients between activity monitor outcome and EE mea-
sured by metabolic cart/chamber were extracted. A sub-
analysis included to compare correlation coefficients
derived from walking based protocols to correlation
coefficients derived from protocols based on activities
of daily living. Agreement between energy expenditure
outcomes from the activity monitor versus criterion
method (indirect calorimetry) were extracted by the
mean difference at different treadmill walking speeds;
slow walk (<3.2 km/hr or 1 mph), intermediate speed
walk (3.2-6.4 km/hr or 2–4 mph), fast walk (6.5-
8.05 km/hr or 4–5 mph) and running (8.06-11 km/hr or
5–7 mph). Accuracy of steps measured by activity moni-
toring was expressed as the percentage mean difference
between steps measured by an activity monitor versus
actual steps measured by the criterion method (video
observation and/or manual step counting).
Statistical analysis
Descriptive statistics were used to report information
about type of activity monitor, activity monitor outcomes
and studied population. Papers were separated by type
of validation, ‘field validation papers’ (validation of an ac-
tivity monitor against indirect calorimetry, using the
doubly labelled water technique) and ‘lab validation
papers’ (validation of an activity monitor against indirect
calorimetry, using a metabolic cart, metabolic chamber
or direct observation).
We also analysed the results separately per type of de-
vice (uni-, bi-, triaxial and multisensor devices). We per-
formed (DerSimonian and Laird) random-effects meta-
Figure 3 Study-specific % mean difference (diamond) between total energy expenditure estimate from the activity monitor (TEEAM)
and total energy expenditure measure from doubly labelled water (TEEDLW). Each dot represents the mean difference of the respective
study together with a 95% confidence interval (CI) and the size of the box represents the weight of the study in the meta-analysis. Weights are
from random effects analysis. CV; coefficient of variation for TEEDLW. *Leenders et al. 2006 (Actigraph Model 7164); TEEAM estimated with most
frequently used Freedson and Hendelman equation (walking outdoors), (not reported) data of % mean difference (±SD) between TEEAM - TEEDLW
with other previously published equations can be found in the original paper [14].
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analyses to pool the correlation coefficients and mean
differences across studies and expressed heterogeneity
by the I2 statistic, which estimates the percentage of
total variation between studies that is due to heterogen-
eity rather than chance. I2 is calculated from basic
results obtained from a typical meta-analysis as
I2 = 100% x (Q-df)/Q, where Q is Cochran’s heterogen-
eity statistic and df the degrees of freedom. Negative
values of I2 are put equal to zero so that I2 lies between
0% en 100% with larger values showing larger heterogen-
eity. We used the Fisher r to z-transformation in order
to pool normally distributed data (z scores) rather than
the skewed distribution of Pearson correlation coeffi-
cients [13]. We back transformed the pooled z-scores to
correlation coefficients for easier interpretation.
We used random-effects linear regression models
(meta-regression analyses) with the studies’ results as
the dependent variable (and considering each studies’
standard error) to compare the type of devices (covari-
ate) and to assess the type of population (covariate) as a
potential explanation for heterogeneity. For those few
studies where no measures of variability were reported
we imputed the median standard deviations of those
studies where the standard deviation was available. We
did not perform meta-analyses for the laboratory studies
where none of the studies provided standard deviations
for ΔTEE and ΔAEE but presented the point estimates
as graphs. Coefficient of variation for TEEDLW and
AEEDLW was calculated per study population to investi-
gate whether the degree of variation in TEEDLW and
AEEDLW affected the correlation coefficients and/or
mean differences, (i.e. higher correlations/mean differ-
ences in populations with larger variation in TEE and/or
AEE).
Results
The systematic literature search resulted in a total of
2875 abstracts which were scrutinised by four review
teams across Europe. Figure 1 represents the different
processes used in the systematic review.
Forty monitors were tested in validation studies; 12
uniaxial, 3 biaxial, 16 triaxial accelerometers and 9 mul-
tisensor devices. Fifty-five percent of activity monitors
(22/40) were used only in lab validation studies, 10% (4/
40) only in field validation studies and 35% (14/40) in
both a lab as well as a field validation study. An
Figure 4 Study-specific correlation coefficients and Fisher z-scores (diamond) between active energy expenditure estimate from the
activity monitor (AEEAM) and active energy expenditure measure from doubly labelled water (AEEDLW). Each dot represents the z-score of
the respective study together with a 95% confidence interval (CI) and the size of the box represents the weight of the study in the meta-analysis.
Weights are from random effects analysis. CV; coefficient of variation for AEEDLW.
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overview of the different activity monitors is shown in
Tables 1, 2, 3 and 4.
The most frequently available outcomes present in
validated activity monitors are (total and/or active) en-
ergy expenditure (70%, 28/40), steps (38%, 15/40) and
different levels of physical activity intensity (38%, 15/
40). The majority of the validation studies (118/134,
88%) were performed in healthy adults. Few studies (16/
134, 12%) were performed in chronic disease popula-
tions; obesity (n = 4), chronic obstructive pulmonary
disease (n = 5), chronic heart failure (n = 1), chronic
organ failure (n = 1), chronic low back pain (n = 1),
fibromyalgia syndrome (n = 1), peripheral arterial dis-
ease (n = 1), diabetes mellitus type II (n = 1) and a gen-
eral chronic disease population (cardiac, obese or knee
arthritis, n = 1).
Field validation studies
Individual correlation coefficients, with converted Fisher
z-scores, for total energy expenditure (TEE) between
TEEAM and TEEDLW are presented in Figure 2.
Variability of study populations’ TEEDLW was relatively
small; coefficient of variation (CV) ranged from 0.11 to
0.29. Pooled r in uniaxial devices (r = 0.52 (95%CI, 0.29 to
0.70)) was significantly lower compared to multisensor
devices (r = 0.84 (95%CI, 0.78 to 0.88), p<0.001) but not
to triaxial devices (r = 0.61 (95%CI, 0.45 to 0.73, p = 0.37)).
Because of the relatively large difference in accuracy be-
tween the uniaxial, the triaxial and multisensor devices
53% of the between–study heterogeneity was accounted
for by type of device in meta-regression analyses.
ΔTEE (TEEAM – TEEDLW) was less accurate in uni-
axial compared to triaxial accelerometers and multisen-
sor devices (−12.07 (95%CI, -18.28 to −5.85) % in
uniaxial versus −6.85 (95%CI, -18.20 to 4.49) % in tri-
axial (p = 0.39 for comparison against uniaxial devices)
and −3.64 (95%CI, -8.97 to 1.70) % in multisensor
devices, p = 0.03 for comparison against uniaxial devices,
Figure 3). ΔTEE were smaller in studies with chronic
disease populations than in studies with healthy popula-
tions (−9% (95%CI −19 to 1)) but the difference did not
reach statistical significance (p = 0.09).
Figure 5 Study-specific % mean difference (diamond) between active energy expenditure estimate from the activity monitor (AEEAM)
and total energy expenditure measure from doubly labelled water (AEEDLW). Each dot represents the mean difference of the respective
study together with a 95% confidence interval (CI) and the size of the box represents the weight of the study in the meta-analysis. Weights are
from random effects analysis. CV; coefficient of variation for AEEDLW. *Assah et al. 2009 (Actigraph Model 7164); AEEAM estimated with most
frequently used Freedson and Hendelman equation, (not reported) data of % mean difference between AEEAM - AEEDLW with other data derived
and previously published equations can be found in the original paper [48].
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Figure 6 (See legend on next page.)
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Correlations for active energy expenditure (AEE) be-
tween AEEAM and AEEDLW were higher in triaxial (0.59
(95%CI, 0.45 to 0.70)) and multisensor devices (0.54
(95%CI, 0.39 to 0.65)) compared to uniaxial (0.39 (95%
CI, 0.16 to 0.58)) devices, p = 0.12 for triaxial and
p = 0.32 for multisensor against uniaxial devices)
(Figure 4) Types of devices accounted for only 12% of
the between-study heterogeneity in the meta-regression
analysis. All monitors underestimated AEE (ΔAEE
(AEEAM – AEEDLW) -24.22 (95%CI, -62.05 to −13.61) %
in uniaxial, -21.01 (95%CI, -41.92 to −0.11) % in triaxial
and −24.35 (95%CI, -45.28 to −3.42) % in multisensor
devices. No significant differences were found between
devices (Figure 5). But ΔAEE were statistically signifi-
cantly smaller in studies with chronic disease popula-
tions than in studies with healthy populations (−44%,
95%CI −73 to −13, p = 0.006).
Laboratory validation studies
For correlation analysis, TEE and AEE, as determined
from indirect calorimetry, were used as criterion out-
comes (in 89% and 11% of the studies, respectively)
against different outcomes of the activity monitor (activ-
ity counts (37%), vector magnitude units (7%), total en-
ergy expenditure (48%), active energy expenditure (2%)
or monitor-specific activity scores (6%).
Pooled correlation coefficients between indirect calor-
imetry (TEEIC) and activity monitor outcome were lower
in uniaxial (0.80 (95%CI, 0.75 to 0.84)) compared to
multisensor devices (0.85 (95%CI, 0.72 to 0.92)) but the
difference did not reach statistical significance (p = 0.43)
No differences were found with biaxial (0.73 (95%CI,
0.33 to 0.91), p = 0.50) and triaxial (0.84 (95%CI, 0.78 to
0.89), p = 0.28) devices, either (Figure 6).
Correlation coefficients between TEEIC and activity
monitor outcome were higher when tested using labora-
tory protocols based on walking activities (overall pooled
r = 0.84 (95%CI, 0.79 to 0.87), no significant differences
between types of devices, Figure 7) compared to proto-
cols using activities of daily living involving the upper
and lower limbs (overall pooled r = 0.75 (95%CI, 0.68 to
0.81, no significant differences between types of devices),
Figure 8).
There was evidence of heterogeneity of results across
all analyses (overall I2 ranged from 84.6% (Figure 7) to
85.9% (Figure 8)). Again, the results did not differ for
chronic disease and healthy populations in any of the
analyses on laboratory validation studies.
Mean differences between TEEAM and TEEIC at dif-
ferent treadmill walking speeds are presented in Fig-
ures 9, 10, 11 and 12. TEE was underestimated during
slow walking speed in 69% of studies (n = 16/23),
whereas in only 37% of studies (n = 15/40) during inter-
mediate walking speed, 30% of studies (n = 10/33) dur-
ing fast walking speed and 37% of studies (n = 7/19)
during running reported underestimation of TEE.
Underestimations in the slow walking group were rela-
tively larger.
All accelerometers underestimate steps during slow
walking; from 0.94 to 60% underestimation. One uniaxial
device (activPAL), mounted on the thigh, showed a high
accuracy in measuring steps during slow walking with
only 0.94% overestimation. More accurate estimates of
steps were reported at higher speeds; from 13% under to
2% overestimation during intermediate walking speed
(except one study with 35% underestimation using Sen-
seWear Armband), and from 0.18 to 4.3% overesti-
mation during fast walking (Figure 13).
Discussion
This systematic review of the literature identified forty
activity monitors (12 uniaxial, 3 biaxial, 16 triaxial and
9 multisensor devices) that had been validated against
indirect calorimetry (doubly labelled water, metabolic
cart and/or metabolic chamber) in healthy adults (88%
of studies) or adults with chronic disease (12% of
studies).
Field and laboratory validation studies had highly het-
erogeneous results which could partly be explained by
the type of activity monitor and the activity monitor out-
come. These factors need consideration when a valid-
ation study is evaluated.
First, selecting the type of activity monitor is import-
ant. Pedometers are limited in their ability to detect cer-
tain physical activity patterns which might occur in
chronic disease populations (for example, an unstable
gait profile or lack of intensity of physical activity).
Accelerometers can overcome this. Multi-axial acceler-
ometers have the ability to measure accelerations in dif-
ferent orientations, which provides information about
the total amount, intensity and duration of daily physical
activity. Some multisensor devices, which combine
(See figure on previous page.)
Figure 6 Study-specific correlation coefficients (r) and Fisher z-scores (diamond) between activity monitor outcomes and total energy
expenditure measure from indirect calorimetry (TEEIC) during laboratory protocols. Each dot represents the z-score of the respective study
together with a 95% confidence interval (CI) and the size of the box represents the weight of the study in the meta-analysis. Weights are from
random effects analysis.
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Figure 7 Study-specific correlation coefficients and Fisher z-scores (diamond) between activity monitor outcomes and total energy
expenditure measure from indirect calorimetry (TEEIC) during laboratory protocols based on walking activities. Each dot represents the
z-score of the respective study together with a 95% confidence interval (CI) and the size of the box represents the weight of the study in the
meta-analysis. Weights are from random effects analysis.
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physiological parameters with accelerometry, are avail-
able to assess both body posture and body movement.
An additional promising class of monitors integrate
positioning systems (Global Positioning System (GPS)
and BluetoothW systems for outdoor and indoor activ-
ities respectively) with accelerometry and other sensors.
However, to date, these have been used infrequently in
patients with chronic disease [142,143]. Based on this
systematic review, heterogeneity among studies was sig-
nificantly explained by the types of devices, although no
statistical significance was reached between different
types of devices.
A second factor to take into consideration is the activ-
ity monitor outcome. When measuring TEE in field val-
idation studies (doubly labelled water), high correlations
with the TEE estimate of the activity monitor were
found in most activity monitors. These correlations are,
however, to a large extent driven by patient characteris-
tics (i.e. body weight, age, height) [87] which is an im-
portant predictor of TEE. Consequently, the comparison
of TEE estimated from activity monitors, with TEE mea-
sured with indirect calorimetry or doubly labelled water
is not necessarily a proof of validation. In a field setting
it has been reported that only 19% of the TEE is
accounted for by physical activity in both healthy sub-
jects [87] and in patients with coronary heart disease
[144].
Another factor that needs to be considered is the study
population. Most of the study populations (88%) were
healthy adults (from young healthy adults to healthy eld-
erly). Only 12% of validation studies were performed in
patients with chronic diseases (COPD, chronic heart fail-
ure, chronic organ failure, diabetes mellitus type II,
obesity, peripheral arterial disease chronic low back pain
Figure 8 Study-specific correlation coefficients and Fisher z-scores (diamond) between activity monitor outcomes and total energy
expenditure measure from indirect calorimetry (TEEIC) during laboratory protocols based on activities of daily living activities
involving the upper and lower limbs. Each dot represents the z-score of the respective study together with a 95% confidence interval (CI) and
the size of the box represents the weight of the study in the meta-analysis. Weights are from random effects analysis.
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and fibromyalgia syndrome). These patients walk more
slowly than healthy subjects, which is reflected, for ex-
ample, by a reduced six minute walking distance
[145,146]. This review, as well as original research [147],
suggests that most monitors are less accurate at lower
walking speeds. These findings are consistent with a sys-
tematic review of pedometers which found evidence of
reduced accuracy during slow walking [148]. Hence,
there is a need to perform validation studies specifically
in chronic disease populations.
When measuring TEE in lab validation studies by as-
sessment of oxygen consumption, higher correlations
were reported for walking activities compared to other
daily life activities which implies that the walking com-
ponent of physical activity is better detected than other
activities of daily living.
Most activity monitors use prediction equations to cal-
culate energy expenditure from the activity signals. This
is helpful to validate monitors against indirect calorim-
etry, but, given the inherent inaccuracy of these esti-
mates and fundamental differences between the different
prediction equations (some of which are proprietary to
particular device manufacturers), perhaps greater weight
should be given to direct monitor outputs (steps, activity
counts, VMU, etc.) and their relation to activity energy
expenditure (AEE), rather than the ability of a monitor
to estimate energy expenditure precisely [48,87-89]. It is
very unlikely that an activity monitor will be able to cap-
ture accurately all the factors affecting energy expend-
iture (i.e. movement efficiency, resting metabolism,
distribution of fat-free mass and fat mass). In patients
with COPD, for example, Baarends et al. showed that
non-resting energy expenditure (TEE-REE) was elevated
in COPD compared to healthy controls [149]. Since it is
generally accepted now that these patients are less active
than healthy controls [150,151], it is clear that patients
Figure 9 Study-specific % mean difference (diamond) between total energy expenditure estimate from the activity monitor (TEEAM)
and total energy expenditure measure from indirect calorimetry (TEEIC) during laboratory protocols based on slow walking speed.
Each dot represents the % mean difference of the respective study.
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expend more energy than controls to achieve the same
movements. It would be unrealistic to expect an activity
monitor to pick this up. Hence, the lack of accuracy
against energy expenditure does not render activity
monitors invalid tools to assess physical activity in
patients over time (for which precision is more import-
ant) or to capture the physical activity level of a patient
(for which validity, represented by the correlation with
true energy expenditure is more important than absolute
accuracy). The acceptable correlations between VO2 and
activity monitor outputs in triaxial and multisensor
devices are therefore encouraging for the use of monitors
to assess physical activity in an adult population. With
specific validation studies, these findings can possibly be
extrapolated to elderly and patients with chronic
diseases.
The current systematic review may also help research-
ers to decide on appropriate activity monitor outcomes.
Combination of the three most frequently available out-
comes (TEE/AEE, steps and different levels of physical
activity intensity), which is likely to provide a compre-
hensive insight in overall physical activity of a patient, is
available in 3 uniaxial (Actigraph 7164/GT1M, Kenz
Lifecorder EX and Polar Activity Watch 200), 1 biaxial
(Biotrainer Pro), 3 triaxial (Dynaport Minimod, Actical
and Actigraph GT3X) and 2 multisensor activity moni-
tors (SenseWear Armband and multisensor board).
Some general considerations can also be taken into ac-
count when selecting an activity monitor in clinical trials
such as the type of monitoring (e.g. daily physical activ-
ity), size and scope of the study, usability of the monitor
and cost [152].
Figure 10 Study-specific % mean difference (diamond) between total energy expenditure estimate from the activity monitor (TEEAM)
and total energy expenditure measure from indirect calorimetry (TEEIC) during laboratory protocols based on intermediate walking
speed. Each dot represents the % mean difference of the respective study.
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Methodological issues
A point of difficulty in collecting, analysing and inter-
preting the data was the wide range of statistical
approaches used in the original papers. Indeed, we had
to compute the standard deviation of the mean differ-
ence (between EEAM and EEIC) because some field valid-
ation studies didn’t report this.
Correlation analysis but also Bland and Altman ana-
lysis were the two main statistical approaches used in
validation studies and were used for data extraction. A
systematic review of the statistical methods used to val-
idate physical activity questionnaires revealed similar
findings, with the majority of the studies using correl-
ation analysis compared to Bland and Altman analysis
[153]. Correlation analyses are a common evaluation ap-
proach and allow statements on validity, whereas agree-
ment between activity monitor and criterion method
(indirect calorimetry) with Bland and Altman plots are
preferred when the aim is to identify systematic bias in
measures [154]. Since not all activity monitors have the
possibility to estimate total and/or active energy ex-
penditure, this type of analysis is not uniformly applic-
able. Multiple regression analysis with TEE/AEE as the
dependent variable is a correct technique to tackle this
[87]. Consistent statistical guidelines for reporting the
validity of an activity monitor would be helpful.
Conclusion
Validation studies of activity monitors are highly hetero-
geneous, and this is partly explained by the type of activ-
ity monitor and the activity monitor outcome. Since
activity monitors are less accurate at slow walking
speeds and information about validated activity monitors
in chronic disease populations is lacking, proper valid-
ation studies in these populations are needed prior to
their inclusion in clinical trials.
Figure 11 Study-specific % mean difference (diamond) between total energy expenditure estimate from the activity monitor (TEEAM)
and total energy expenditure measure from indirect calorimetry (TEEIC) during laboratory protocols based on fast walking speed. Each
dot represents the % mean difference of the respective study.
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Figure 12 Study-specific % mean difference (diamond) between total energy expenditure estimate from the activity monitor (TEEAM)
and total energy expenditure measure from indirect calorimetry (TEEIC) during laboratory protocols based on running speed. Each dot
represents the % mean difference of the respective study.
Figure 13 Accuracy of steps at different walking speeds. The dots are reflecting walking speed: slow walking (<3.2 km/hr (□)), intermediate
walking (3.2-6.4 km/hr (■)) and fast walking (6.5-8 km/hr (▲)).
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